{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,31]],"date-time":"2025-12-31T00:03:04Z","timestamp":1767139384822,"version":"build-2238731810"},"reference-count":73,"publisher":"Springer Science and Business Media LLC","issue":"8","license":[{"start":{"date-parts":[[2021,7,2]],"date-time":"2021-07-02T00:00:00Z","timestamp":1625184000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2021,7,2]],"date-time":"2021-07-02T00:00:00Z","timestamp":1625184000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Hautarzt"],"published-print":{"date-parts":[[2021,8]]},"DOI":"10.1007\/s00105-021-04848-8","type":"journal-article","created":{"date-parts":[[2021,7,2]],"date-time":"2021-07-02T10:03:03Z","timestamp":1625220183000},"page":"666-675","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Klinische, pathologische und molekulare Biomarker der Hidradenitis suppurativa\/Acne inversa","Clinical, pathology-associated and molecular biomarkers of hidradenitis suppurativa\/acne inversa"],"prefix":"10.1007","volume":"72","author":[{"given":"M.","family":"von Laffert","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"R. E.","family":"Hunger","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A. A.","family":"Navarini","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1646-2608","authenticated-orcid":false,"given":"C. C.","family":"Zouboulis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2021,7,2]]},"reference":[{"issue":"suppl 93","key":"4848_CR1","first-page":"S2","volume":"33","author":"W Alwan","year":"2015","unstructured":"Alwan\u00a0W, Nestle\u00a0FO (2015) Pathogenesis and treatment of psoriasis: exploiting pathophysiological pathways for precision medicine. Clin Exp Rheumatol 33(suppl 93):S2\u2013S6","journal-title":"Clin Exp Rheumatol"},{"key":"4848_CR2","first-page":"73","volume":"43","author":"S Balabanova","year":"1992","unstructured":"Balabanova\u00a0S, Buhler\u00a0G, Schneider\u00a0E, Boschek\u00a0HJ, Schneitler\u00a0H (1992) \u00dcber die Ausscheidung von Nikotin mit dem apokrinen und ekkrinen Schwei\u00df bei Rauchern und Passivrauchern. Hautarzt 43:73\u201376","journal-title":"Hautarzt"},{"key":"4848_CR3","doi-asserted-by":"publisher","first-page":"1392","DOI":"10.1111\/bjd.14371","volume":"174","author":"JL Blok","year":"2016","unstructured":"Blok\u00a0JL, Li\u00a0K, Brodmerkel\u00a0C, Jonkman\u00a0MF, Horv\u00e1th\u00a0B (2016) Gene expression profiling of skin and blood in hidradenitis suppurativa. Br J Dermatol 174:1392\u20131394","journal-title":"Br J Dermatol"},{"key":"4848_CR4","doi-asserted-by":"publisher","first-page":"721","DOI":"10.1111\/j.1365-2133.1996.tb03880.x","volume":"135","author":"J Boer","year":"1996","unstructured":"Boer\u00a0J, Weltevreden\u00a0EF (1996) Hidradenitis suppurativa or acne inversa. A clinicopathological study of early lesions. Br J Dermatol 135:721\u2013725","journal-title":"Br J Dermatol"},{"key":"4848_CR5","doi-asserted-by":"publisher","first-page":"12207","DOI":"10.1038\/s41598-019-48226-w","volume":"9","author":"AS Byrd","year":"2019","unstructured":"Byrd\u00a0AS, Dina\u00a0Y, Okoh\u00a0UJ et\u00a0al (2019) Specimen collection for translational studies in hidradenitis suppurativa. Sci Rep 9:12207","journal-title":"Sci Rep"},{"key":"4848_CR6","doi-asserted-by":"publisher","DOI":"10.23736\/S2784-8671.21.06966-8","author":"RD Caposiena Caro","year":"2021","unstructured":"Caposiena Caro\u00a0RD, Chiricozzi\u00a0A, Sechi\u00a0A et\u00a0al (2021) Factors related to the onset and recurrence of flares in hidradenitis suppurativa patients treated with adalimumab. Ital J Dermatol Venerol. https:\/\/doi.org\/10.23736\/S2784-8671.21.06966-8","journal-title":"Ital J Dermatol Venerol"},{"key":"4848_CR7","doi-asserted-by":"publisher","first-page":"e0216249","DOI":"10.1371\/journal.pone.0216249","volume":"14","author":"M Coates","year":"2019","unstructured":"Coates\u00a0M, Mariottoni\u00a0P, Corcoran\u00a0DL et\u00a0al (2019) The skin transcriptome in hidradenitis suppurativa uncovers an antimicrobial and sweat gland gene signature which has distinct overlap with wounded skin. PLoS ONE 14:e216249","journal-title":"PLoS ONE"},{"key":"4848_CR8","doi-asserted-by":"publisher","first-page":"1034","DOI":"10.1111\/bjd.12233","volume":"168","author":"FW Danby","year":"2013","unstructured":"Danby\u00a0FW, Jemec\u00a0GB, Marsch\u00a0WC, von Laffert\u00a0M (2013) Preliminary findings suggest hidradenitis suppurativa may be due to defective follicular support. Br J Dermatol 168:1034\u20131039","journal-title":"Br J Dermatol"},{"key":"4848_CR9","doi-asserted-by":"publisher","first-page":"1953","DOI":"10.1016\/j.jaci.2018.01.010","volume":"141","author":"V De Vita","year":"2018","unstructured":"De Vita\u00a0V, McGonagle\u00a0D (2018) Hidradenitis suppurativa as an autoinflammatory keratinization disease. J\u00a0Allergy Clin Immunol 141:1953","journal-title":"J Allergy Clin Immunol"},{"key":"4848_CR10","doi-asserted-by":"publisher","first-page":"673","DOI":"10.1007\/s00403-017-1769-5","volume":"309","author":"R Di Caprio","year":"2017","unstructured":"Di Caprio\u00a0R, Balato\u00a0A, Caiazzo\u00a0G et al (2017) IL-36 cytokines are increased in acne and hidradenitis suppurativa. Arch Dermatol Res 309:673\u2013678","journal-title":"Arch Dermatol Res"},{"key":"4848_CR11","doi-asserted-by":"publisher","first-page":"820","DOI":"10.1111\/exd.14273","volume":"30","author":"RW Dunstan","year":"2020","unstructured":"Dunstan\u00a0RW, Salte\u00a0KM, Todorovi\u0107\u00a0V et\u00a0al (2020) Histologic progression of acne inversa\/hidradenitis suppurativa: implications for future investigations and therapeutic intervention. Exp Dermatol 30:820\u2013830","journal-title":"Exp Dermatol"},{"key":"4848_CR12","doi-asserted-by":"publisher","first-page":"1023","DOI":"10.1111\/j.1365-2133.2011.10765.x","volume":"166","author":"VU Emelianov","year":"2012","unstructured":"Emelianov\u00a0VU, Bechara\u00a0FG, Glaser\u00a0R et al (2012) Immunohistological pointers to a\u00a0possible role for excessive cathelicidin (LL-37) expression by apocrine sweat glands in the pathogenesis of hidradenitis suppurativa\/acne inversa. Br J Dermatol 166:1023\u20131034","journal-title":"Br J Dermatol"},{"key":"4848_CR13","doi-asserted-by":"publisher","first-page":"433","DOI":"10.1111\/j.1600-0463.2011.02771.x","volume":"120","author":"S Fismen","year":"2012","unstructured":"Fismen\u00a0S, Ingvarsson\u00a0G, Moseng\u00a0D, Dufour\u00a0DN, J\u00f8rgensen\u00a0L (2012) A clinical-pathological review of hidradenitis suppurativa: using immunohistochemistry one disease becomes two. Apmis 120:433\u2013440","journal-title":"Apmis"},{"key":"4848_CR14","doi-asserted-by":"publisher","first-page":"566","DOI":"10.1111\/bjd.17695","volume":"181","author":"JM Frew","year":"2019","unstructured":"Frew\u00a0JM, Hawkes\u00a0JE, Sullivan-Whalen\u00a0M, Gilleaudeau\u00a0P, Krueger\u00a0JG (2019) Inter-rater reliability of phenotypes and exploratory genotype-phenotype analysis in inherited hidradenitis suppurativa. Br J Dermatol 181:566\u2013571","journal-title":"Br J Dermatol"},{"key":"4848_CR15","doi-asserted-by":"publisher","first-page":"8851","DOI":"10.1073\/pnas.0701764104","volume":"104","author":"E Fritsche","year":"2007","unstructured":"Fritsche\u00a0E, Sch\u00e4fer\u00a0C, Calles\u00a0C et\u00a0al (2007) Lightening up the UV response by identification of the arylhydrocarbon receptor as a\u00a0cytoplasmatic target for ultraviolet B radiation. Proc Natl Acad Sci U S\u00a0A 104:8851\u20138856","journal-title":"Proc Natl Acad Sci U S A"},{"key":"4848_CR16","doi-asserted-by":"publisher","first-page":"1592","DOI":"10.1016\/j.jid.2016.04.021","volume":"136","author":"EJ Giamarellos-Bourboulis","year":"2016","unstructured":"Giamarellos-Bourboulis\u00a0EJ, Platzer\u00a0M, Karagiannidis\u00a0I et al (2016) High copy numbers of beta-defensin cluster on 8p23.1 confer genetic susceptibility and modulate the physical course of hidradenitis suppurativa\/acne inversa. J\u00a0Invest Dermatol 136:1592\u20131598","journal-title":"J Invest Dermatol"},{"key":"4848_CR17","doi-asserted-by":"publisher","first-page":"361","DOI":"10.1111\/j.0906-6705.2004.00166.x","volume":"13","author":"R Gniadecki","year":"2004","unstructured":"Gniadecki\u00a0R, Jemec\u00a0GB (2004) Lipid raft-enriched stem cell-like keratinocytes in the epidermis, hair follicles and sinus tracts in hidradenitis suppurativa. Exp Dermatol 13:361\u2013363","journal-title":"Exp Dermatol"},{"key":"4848_CR18","first-page":"CS14","volume":"15","author":"RS Goertz","year":"2009","unstructured":"Goertz\u00a0RS, Konturek\u00a0PC, Naegel\u00a0A et al (2009) Experiences with a\u00a0long-term treatment of a\u00a0massive gluteal acne inversa with infliximab in Crohn\u2019s disease. Med Sci Monit 15:CS14\u2013CS18","journal-title":"Med Sci Monit"},{"key":"4848_CR19","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1111\/exd.14056","volume":"29","author":"D Grand","year":"2020","unstructured":"Grand\u00a0D, Navrazhina\u00a0K, Frew\u00a0JW (2020) Integrating complement into the molecular pathogenesis of hidradenitis suppurativa. Exp Dermatol 29:86\u201392","journal-title":"Exp Dermatol"},{"key":"4848_CR20","doi-asserted-by":"publisher","first-page":"2214","DOI":"10.1016\/j.lfs.2007.02.007","volume":"80","author":"A Hana","year":"2007","unstructured":"Hana\u00a0A, Booken\u00a0D, Henrich\u00a0C et al (2007) Functional significance of non-neuronal acetylcholine in skin epithelia. Life Sci 80:2214\u20132220","journal-title":"Life Sci"},{"key":"4848_CR21","doi-asserted-by":"publisher","first-page":"e0203672","DOI":"10.1371\/journal.pone.0203672","volume":"13","author":"LK Hoffman","year":"2018","unstructured":"Hoffman\u00a0LK, Tomalin\u00a0LE, Schultz\u00a0G et\u00a0al (2018) Integrating the skin and blood transcriptomes and serum proteome in hidradenitis suppurativa reveals complement dysregulation and a\u00a0plasma cell signature. PLoS ONE 13:e203672","journal-title":"PLoS ONE"},{"key":"4848_CR22","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1038\/nrd4537","volume":"14","author":"M Hofmann-Apitius","year":"2015","unstructured":"Hofmann-Apitius\u00a0M, Alarc\u00f3n-Riquelme\u00a0ME, Chamberlain\u00a0C, McHale\u00a0D (2015) Towards the taxonomy of human disease. Nat Rev Drug Discov 14:75\u201376","journal-title":"Nat Rev Drug Discov"},{"key":"4848_CR23","doi-asserted-by":"publisher","first-page":"1768","DOI":"10.1016\/j.jid.2016.04.036","volume":"136","author":"C Hotz","year":"2016","unstructured":"Hotz\u00a0C, Boniotto\u00a0M, Guguin\u00a0A et\u00a0al (2016) Intrinsic defect in keratinocyte function leads to inflammation in hidradenitis suppurativa. J\u00a0Invest Dermatol 136:1768\u20131780","journal-title":"J Invest Dermatol"},{"key":"4848_CR24","unstructured":"https:\/\/clinicaltrials.gov\/ct2\/results?recrs=&cond=Hidradenitis+Suppurativa&term=&cntry=&state=&city=&dist=. Zugegriffen: 4. M\u00e4rz 2021"},{"key":"4848_CR25","doi-asserted-by":"publisher","first-page":"691","DOI":"10.1111\/j.1365-2133.2007.08425.x","volume":"158","author":"RE Hunger","year":"2008","unstructured":"Hunger\u00a0RE, Surovy\u00a0AM, Hassan\u00a0AS, Braathen\u00a0LR, Yawalkar\u00a0N (2008) Toll-like receptor 2 is highly expressed in lesions of acne inversa and colocalizes with C\u2011type lectin receptor. Br J Dermatol 158:691\u2013697","journal-title":"Br J Dermatol"},{"key":"4848_CR26","doi-asserted-by":"publisher","first-page":"e14919","DOI":"10.1111\/dth.14919","volume":"34","author":"M Iannone","year":"2021","unstructured":"Iannone\u00a0M, Janowska\u00a0A, Bartolomei\u00a0G et al (2021) Systemic antibiotics in hidradenitis suppurativa: efficacy and effects of body mass index and smoking pack-year on the response to therapy. Dermatol Ther 34:e14919","journal-title":"Dermatol Ther"},{"key":"4848_CR27","doi-asserted-by":"publisher","first-page":"994","DOI":"10.1016\/S0190-9622(96)90277-7","volume":"34","author":"G Jemec","year":"1996","unstructured":"Jemec\u00a0G, Hansen\u00a0U (1996) Histology of hidradenitis suppurativa. J\u00a0Am Acad Dermatol 34:994\u2013999","journal-title":"J Am Acad Dermatol"},{"key":"4848_CR28","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1177\/120347540300700109","volume":"7","author":"GB Jemec","year":"2003","unstructured":"Jemec\u00a0GB (2003) Hidradenitis suppurativa. J\u00a0Cutan Med Surg 7:47\u201356","journal-title":"J Cutan Med Surg"},{"key":"4848_CR29","doi-asserted-by":"publisher","first-page":"964","DOI":"10.1016\/j.jid.2018.10.020","volume":"139","author":"A Jenei","year":"2019","unstructured":"Jenei\u00a0A, Dajnoki\u00a0Z, Medgyesi\u00a0B et al (2019) Apocrine gland-rich skin has a\u00a0non-inflammatory IL-17 related immune milieu, which turns to inflammatory IL-17 mediated disease in hidradenitis suppurativa. J\u00a0Invest Dermatol 139:964\u2013968","journal-title":"J Invest Dermatol"},{"key":"4848_CR30","doi-asserted-by":"publisher","first-page":"2450401","DOI":"10.1155\/2017\/2450401","volume":"2017","author":"D Jimenez-Gallo","year":"2017","unstructured":"Jimenez-Gallo\u00a0D, de la Varga-Martinez\u00a0R, Ossorio-Garcia\u00a0L, Albarran-Planelles\u00a0C, Rodriguez\u00a0C, Linares-Barrios\u00a0M (2017) The clinical significance of increased serum proinflammatory cytokines, c\u2011reactive protein, and erythrocyte sedimentation rate in patients with hidradenitis suppurativa. Mediators Inflamm 2017:2450401","journal-title":"Mediators Inflamm"},{"key":"4848_CR31","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1016\/j.cyto.2017.12.020","volume":"103","author":"D Jimenez-Gallo","year":"2018","unstructured":"Jimenez-Gallo\u00a0D, de la Varga-Martinez\u00a0R, Ossorio-Garcia\u00a0L, Collantes-Rodriguez\u00a0C, Rodriguez\u00a0C, Linares-Barrios\u00a0M (2018) Effects of adalimumab on T\u2011helper-17 lymphocyte- and neutrophil-related inflammatory serum markers in patients with moderate-to-severe hidradenitis suppurativa. Cytokine 103:20\u201324","journal-title":"Cytokine"},{"key":"4848_CR32","first-page":"761","volume":"44","author":"Q Ju","year":"2011","unstructured":"Ju\u00a0Q, Yu\u00a0Q, Song\u00a0N, Tan\u00a0Y, Xia\u00a0L, Zouboulis\u00a0CC (2011) Expression of aryl hydrocarbon receptor in human epidermis, hair follicles and sebaceous glands and its significance. Chin J Dermatol 44:761\u2013764","journal-title":"Chin J Dermatol"},{"key":"4848_CR33","doi-asserted-by":"publisher","first-page":"1017","DOI":"10.1111\/j.1365-2133.2011.10224.x","volume":"164","author":"S Kamp","year":"2011","unstructured":"Kamp\u00a0S, Fiehn\u00a0AM, Stenderup\u00a0K et\u00a0al (2011) Hidradenitis suppurativa: a\u00a0disease of the absent sebaceous gland? Sebaceous gland number and volume are significantly reduced in uninvolved hair follicles from patients with hidradenitis suppurativa. Br J Dermatol 164:1017\u20131022","journal-title":"Br J Dermatol"},{"key":"4848_CR34","first-page":"390","volume":"12","author":"J Kanitakis","year":"2002","unstructured":"Kanitakis\u00a0J (2002) Anatomy, histology and immunohistochemistry of normal human skin. Eur J Dermatol 12:390\u2013401","journal-title":"Eur J Dermatol"},{"key":"4848_CR35","doi-asserted-by":"publisher","first-page":"e0130522","DOI":"10.1371\/journal.pone.0130522","volume":"10","author":"T Kanni","year":"2015","unstructured":"Kanni\u00a0T, Tzanetakou\u00a0V, Savva\u00a0A et\u00a0al (2015) Compartmentalized cytokine responses in hidradenitis suppurativa. PLoS ONE 10:e130522","journal-title":"PLoS ONE"},{"key":"4848_CR36","doi-asserted-by":"publisher","first-page":"846","DOI":"10.7326\/0003-4819-157-12-201212180-00004","volume":"157","author":"AB Kimball","year":"2012","unstructured":"Kimball\u00a0AB, Kerdel\u00a0F, Adams\u00a0D et\u00a0al (2012) Adalimumab for the treatment of moderate to severe Hidradenitis suppurativa: a\u00a0parallel randomized trial. Ann Intern Med 157:846\u2013855","journal-title":"Ann Intern Med"},{"key":"4848_CR37","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1177\/147323000203000205","volume":"30","author":"I Kurokawa","year":"2002","unstructured":"Kurokawa\u00a0I, Nishijima\u00a0S, Kusumoto\u00a0K, Senzaki\u00a0H, Shikata\u00a0N, Tsubura\u00a0A (2002) Immunohistochemical study of cytokeratins in hidradenitis suppurativa (acne inversa). J\u00a0Int Med Res 30:131\u2013136","journal-title":"J Int Med Res"},{"key":"4848_CR38","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1046\/j.1365-2133.1999.02970.x","volume":"41","author":"H Kurzen","year":"1999","unstructured":"Kurzen\u00a0H, Jung\u00a0EG, Hartschuh\u00a0W et\u00a0al (1999) Forms of epithelial differentiation of draining sinus in acne inversa (hidradenitis suppurativa). Br J Dermatol 41:231\u2013239","journal-title":"Br J Dermatol"},{"key":"4848_CR39","doi-asserted-by":"publisher","first-page":"457","DOI":"10.1111\/j.1600-0625.2008.00712_2.x","volume":"17","author":"H Kurzen","year":"2008","unstructured":"Kurzen\u00a0H, Kurokawa\u00a0I, Jemec\u00a0GB (2008) What causes hidradenitis suppurativa? Exp Dermatol 17:457\u2013472","journal-title":"Exp Dermatol"},{"key":"4848_CR40","doi-asserted-by":"publisher","first-page":"499","DOI":"10.1016\/j.jtho.2019.12.107","volume":"15","author":"S Lantuejoul","year":"2020","unstructured":"Lantuejoul\u00a0S, Sound-Tsao\u00a0M, Cooper\u00a0WA et al (2020) PD-L1 Testing for lung cancer in 2019: Perspective from the IASLC pathology committee. J\u00a0Thorac Oncol 15:499\u2013519","journal-title":"J Thorac Oncol"},{"key":"4848_CR41","doi-asserted-by":"publisher","first-page":"172","DOI":"10.1111\/exd.12098","volume":"22","author":"BC Melnik","year":"2013","unstructured":"Melnik\u00a0BC, Plewig\u00a0G (2013) Impaired Notch-MKP\u20111 signalling in hidradenitis suppurativa: an approach to pathogenesis by evidence from translational biology. Exp Dermatol 22:172\u2013177","journal-title":"Exp Dermatol"},{"key":"4848_CR42","doi-asserted-by":"publisher","first-page":"416","DOI":"10.1038\/ng1099","volume":"33","author":"M Nicolas","year":"2003","unstructured":"Nicolas\u00a0M, Wolfer\u00a0A, Raj\u00a0K et\u00a0al (2003) Notch1 functions as a\u00a0tumor suppressor in mouse skin. Nat Genet 33:416\u2013421","journal-title":"Nat Genet"},{"key":"4848_CR43","doi-asserted-by":"publisher","first-page":"7","DOI":"10.4137\/IJTR.S19985","volume":"8","author":"R Noakes","year":"2015","unstructured":"Noakes\u00a0R (2015) The aryl hydrocarbon receptor: a\u00a0review of its role in the physiology and pathology of the integument and its relationship to the tryptophan metabolism. Int J Tryptophan Res 8:7\u201318","journal-title":"Int J Tryptophan Res"},{"key":"4848_CR44","doi-asserted-by":"publisher","first-page":"532","DOI":"10.1111\/ced.14478","volume":"46","author":"E \u00d6zkur","year":"2021","unstructured":"\u00d6zkur\u00a0E, Karada\u011f\u00a0AS, \u00dcst\u00fcner\u00a0P et\u00a0al (2021) Clinical and demographic features of hidradenitis suppurativa: a\u00a0multicentre study of 1221\u00a0patients with an analysis of risk factors associated with disease severity. Clin Exp Dermatol 46:532\u2013540","journal-title":"Clin Exp Dermatol"},{"key":"4848_CR45","doi-asserted-by":"publisher","first-page":"731","DOI":"10.1016\/j.devcel.2004.09.014","volume":"7","author":"Y Pan","year":"2004","unstructured":"Pan\u00a0Y, Lin\u00a0MH, Tian\u00a0X et al (2004) Gamma-secretase functions through Notch signaling to maintain skin appendages but is not required for their patterning or initial morphogenesis. Dev Cell 7:731\u2013743","journal-title":"Dev Cell"},{"key":"4848_CR46","first-page":"345","volume-title":"Acne and related disorders","author":"G Plewig","year":"1989","unstructured":"Plewig\u00a0G, Steger\u00a0M (1989) Acne inversa (alias acne triad, acne tetrad or hidradenitis suppurativa). In: Marks\u00a0R, Plewig\u00a0G (Hrsg) Acne and related disorders. Martin Dunitz, London, S\u00a0345\u2013357"},{"key":"4848_CR47","doi-asserted-by":"publisher","first-page":"790","DOI":"10.1016\/j.jaad.2010.07.010","volume":"65","author":"C Schlapbach","year":"2011","unstructured":"Schlapbach\u00a0C, Hanni\u00a0T, Yawalkar\u00a0N, Hunger\u00a0RE (2011) Expression of the IL-23\/Th17 pathway in lesions of hidradenitis suppurativa. J\u00a0Am Acad Dermatol 65:790\u2013798","journal-title":"J Am Acad Dermatol"},{"key":"4848_CR48","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1016\/j.jaad.2008.12.033","volume":"61","author":"C Schlapbach","year":"2009","unstructured":"Schlapbach\u00a0C, Yawalkar\u00a0N, Hunger\u00a0RE (2009) Human beta-defensin\u20112 and psoriasin are overexpressed in lesions of acne inversa. J\u00a0Am Acad Dermatol 61:58\u201365","journal-title":"J Am Acad Dermatol"},{"key":"4848_CR49","doi-asserted-by":"publisher","first-page":"460","DOI":"10.1016\/j.jaad.2014.04.001","volume":"71","author":"AMR Schrader","year":"2014","unstructured":"Schrader\u00a0AMR, Deckers\u00a0IE, van der Zee\u00a0HH, Boer\u00a0J, Prens\u00a0EP (2014) Hidradenitis suppurativa: a\u00a0retrospective study of 846 Dutch patients to identify factors associated with disease severity. J\u00a0Am Acad Dermatol 71:460\u2013467","journal-title":"J Am Acad Dermatol"},{"key":"4848_CR50","doi-asserted-by":"publisher","first-page":"882","DOI":"10.1111\/ced.13959","volume":"44","author":"VK Shanmugam","year":"2019","unstructured":"Shanmugam\u00a0VK, Jones\u00a0D, McNish\u00a0S, Bendall\u00a0ML, Crandall\u00a0KA (2019) Transcriptome patterns in hidradenitis suppurativa: support for the role of antimicrobial peptides and interferon pathways in disease pathogenesis. Clin Exp Dermatol 44:882\u2013892","journal-title":"Clin Exp Dermatol"},{"key":"4848_CR51","doi-asserted-by":"publisher","first-page":"2091","DOI":"10.1111\/jdv.14389","volume":"31","author":"R Thomi","year":"2017","unstructured":"Thomi\u00a0R, Kakeda\u00a0M, Yawalkar\u00a0N, Schlapbach\u00a0C, Hunger\u00a0RE (2017) Increased expression of the interleukin-36 cytokines in lesions of hidradenitis suppurativa. J\u00a0Eur Acad Dermatol Venereol 31:2091\u20132096","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"4848_CR52","doi-asserted-by":"publisher","first-page":"172","DOI":"10.1111\/exd.13482","volume":"27","author":"R Thomi","year":"2018","unstructured":"Thomi\u00a0R, Schlapbach\u00a0C, Yawalkar\u00a0N, Simon\u00a0D, Yerly\u00a0D, Hunger\u00a0RE (2018) Elevated levels of the antimicrobial peptide LL-37 in hidradenitis suppurativa are associated with a\u00a0Th1\/Th17 immune response. Exp Dermatol 27:172\u2013177","journal-title":"Exp Dermatol"},{"key":"4848_CR53","doi-asserted-by":"publisher","first-page":"1358","DOI":"10.1111\/bjd.15458","volume":"177","author":"R Thomi","year":"2017","unstructured":"Thomi\u00a0R, Yerly\u00a0D, Yawalkar\u00a0N, Simon\u00a0D, Schlapbach\u00a0C, Hunger\u00a0RE (2017) Interleukin-32 is highly expressed in lesions of hidradenitis suppurativa. Br J Dermatol 177:1358\u20131366","journal-title":"Br J Dermatol"},{"key":"4848_CR54","doi-asserted-by":"publisher","first-page":"892","DOI":"10.3389\/fimmu.2019.00892","volume":"10","author":"P Tricarico","year":"2019","unstructured":"Tricarico\u00a0P, Boniotto\u00a0M, Genovese\u00a0G, Zouboulis\u00a0CC, Marzano\u00a0AV, Crovella\u00a0S (2019) Skin-OMICS: an integrated approach to unravel hidradenitis suppurativa etiopathogenesis. Front Immunol 10:892","journal-title":"Front Immunol"},{"key":"4848_CR55","doi-asserted-by":"publisher","first-page":"1292","DOI":"10.1111\/j.1365-2133.2011.10254.x","volume":"164","author":"HH van der Zee","year":"2011","unstructured":"van der Zee\u00a0HH, de Ruiter\u00a0L, van den Broecke\u00a0DG, Dik\u00a0WA, Laman\u00a0JD, Prens\u00a0EP (2011) Elevated levels of tumour necrosis factor (TNF)-alpha, interleukin (IL)-1beta and IL-10 in hidradenitis suppurativa skin: a\u00a0rationale for targeting TNF-alpha and IL-1beta. Br J Dermatol 164:1292\u20131298","journal-title":"Br J Dermatol"},{"key":"4848_CR56","doi-asserted-by":"publisher","first-page":"735","DOI":"10.1111\/j.1600-0625.2012.01552.x","volume":"21","author":"HH van der Zee","year":"2012","unstructured":"van der Zee\u00a0HH, Laman\u00a0JD, Boer\u00a0J, Prens\u00a0EP (2012) Hidradenitis suppurativa: viewpoint on clinical phenotyping, pathogenesis and novel treatments. Exp Dermatol 21:735\u2013739","journal-title":"Exp Dermatol"},{"key":"4848_CR57","first-page":"537","volume":"2","author":"A Verneuil","year":"1864","unstructured":"Verneuil\u00a0A (1864) De l\u2019hidrosad\u00e9nite phlegmoneuse et des absc\u00e8s sudoripares. Arch Gen Med 2:537\u2013557","journal-title":"Arch Gen Med"},{"key":"4848_CR58","doi-asserted-by":"publisher","first-page":"533","DOI":"10.1111\/j.1600-0625.2009.00915.x","volume":"19","author":"M von Laffert","year":"2010","unstructured":"von Laffert\u00a0M, Helmbold\u00a0P, Wohlrab\u00a0J, Fiedler\u00a0E, Stadie\u00a0V, Marsch\u00a0WC (2010) Hidradenitis suppurativa (acne inversa): early inflammatory events at terminal follicles and at interfollicular epidermis. Exp Dermatol 19:533\u2013537","journal-title":"Exp Dermatol"},{"key":"4848_CR59","doi-asserted-by":"publisher","first-page":"367","DOI":"10.1111\/j.1365-2133.2010.10034.x","volume":"164","author":"M von Laffert","year":"2011","unstructured":"von Laffert\u00a0M, Stadie\u00a0V, Wohlrab\u00a0J, Marsch\u00a0WC (2011) Hidradenitis suppurativa\/acne inversa: bilocated epithelial hyperplasia with very different sequelae. Br J Dermatol 164:367\u2013371","journal-title":"Br J Dermatol"},{"key":"4848_CR60","doi-asserted-by":"publisher","first-page":"314","DOI":"10.1111\/bjd.17641","volume":"181","author":"ARJV Vossen","year":"2019","unstructured":"Vossen\u00a0ARJV, Ardon\u00a0CB, van der Zee\u00a0HH, Lubberts\u00a0E, Prens\u00a0EP (2019) The anti-inflammatory potency of biologics targeting tumour necrosis factor\u2011a, interleukin (IL)-17A, IL-12\/23 and CD20 in hidradenitis suppurativa: an ex vivo study. Br J Dermatol 181:314\u2013323","journal-title":"Br J Dermatol"},{"issue":"6007","key":"4848_CR61","doi-asserted-by":"publisher","first-page":"1065","DOI":"10.1126\/science.1196284","volume":"330","author":"B Wang","year":"2010","unstructured":"Wang\u00a0B, Yang\u00a0W, Wen\u00a0W et al (2010) Gamma-secretase gene mutations in familial acne inversa. Science 330(6007):1065","journal-title":"Science"},{"key":"4848_CR62","doi-asserted-by":"publisher","first-page":"1228","DOI":"10.4049\/jimmunol.0903907","volume":"186","author":"K Wolk","year":"2011","unstructured":"Wolk\u00a0K, Warszawska\u00a0K, Hoeflich\u00a0C et al (2011) Deficiency of IL-22 contributes to a\u00a0chronic inflammatory disease: pathogenetic mechanisms in acne inversa. J\u00a0Immunol 186:1228\u20131239","journal-title":"J Immunol"},{"key":"4848_CR63","doi-asserted-by":"publisher","first-page":"223","DOI":"10.4103\/ijdvl.IJDVL_455_18","volume":"87","author":"CF Yen","year":"2021","unstructured":"Yen\u00a0CF, Huang\u00a0YH, Chi\u00a0CC (2021) Concomitant psoriasis and hidradenitis suppurativa responsive to adalimumab therapy: a case series. Indian J Dermatol Venereol Leprol 87:223\u2013226","journal-title":"Indian J Dermatol Venereol Leprol"},{"key":"4848_CR64","doi-asserted-by":"publisher","first-page":"763","DOI":"10.1111\/j.1365-2133.1990.tb06264.x","volume":"122","author":"CC Yu","year":"1990","unstructured":"Yu\u00a0CC, Cook\u00a0MG (1990) Hidradenitis suppurativa: a\u00a0disease of follicular epithelium, rather than apocrine glands. Br J Dermatol 122:763\u2013769","journal-title":"Br J Dermatol"},{"key":"4848_CR65","doi-asserted-by":"publisher","first-page":"244","DOI":"10.1111\/bjd.18173","volume":"181","author":"CC Zouboulis","year":"2019","unstructured":"Zouboulis\u00a0CC (2019) Ex vivo human models of hidradenitis suppurativa \/ acne inversa for laboratory research and drug screening. Br J Dermatol 181:244\u2013246","journal-title":"Br J Dermatol"},{"key":"4848_CR66","doi-asserted-by":"publisher","first-page":"1154","DOI":"10.1111\/exd.14214","volume":"29","author":"CC Zouboulis","year":"2020","unstructured":"Zouboulis\u00a0CC, Benhadou\u00a0F, Byrd\u00a0A et\u00a0al (2020) What causes hidradenitis suppurativa? 15\u00a0years after. Exp Dermatol 29:1154\u20131170","journal-title":"Exp Dermatol"},{"issue":"suppl\u00a01","key":"4848_CR67","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1111\/exd.14338","volume":"30","author":"CC Zouboulis","year":"2021","unstructured":"Zouboulis CC, Frew JW, Giamarellos-Bourboulis EJ et al (2021) Target molecules for future hidradenitis suppurativa treatment. Exp Dermatol 30(suppl\u00a01):8\u201317","journal-title":"Exp Dermatol"},{"key":"4848_CR68","first-page":"e251","volume":"35","author":"CC Zouboulis","year":"2021","unstructured":"Zouboulis\u00a0CC, Nogueira da Costa\u00a0A (2021) Drug repurposing through drug-gene interaction profiles for hidradenitis suppurativa\/acne inversa treatment. J\u00a0Eur Acad Dermatol Venereol 35:e251\u2013e254","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"4848_CR69","doi-asserted-by":"publisher","first-page":"1555","DOI":"10.1111\/jdv.16264","volume":"34","author":"CC Zouboulis","year":"2020","unstructured":"Zouboulis\u00a0CC, Nogueira da Costa\u00a0A, Fimmel\u00a0A, Zouboulis\u00a0KC (2020) Apocrine glands are bystanders in hidradenitis suppurativa and their involvement is gender-specific. J\u00a0Eur Acad Dermatol Venereol 34:1555\u20131563","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"4848_CR70","doi-asserted-by":"publisher","first-page":"846","DOI":"10.1111\/jdv.16147","volume":"34","author":"CC Zouboulis","year":"2020","unstructured":"Zouboulis\u00a0CC, Nogueira da Costa\u00a0A, Makrantonaki\u00a0E et\u00a0al (2020) Alterations in innate immunity and epithelial cell differentiation are the molecular pillars of hidradenitis suppurativa. J\u00a0Eur Acad Dermatol Venereol 34:846\u2013861","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"4848_CR71","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1016\/j.jaad.2018.05.040","volume":"80","author":"CC Zouboulis","year":"2019","unstructured":"Zouboulis\u00a0CC, Okun\u00a0MM, Prens\u00a0EP et al (2019) Long-term adalimumab efficacy in patients with moderate-to-severe hidradenitis suppurativa\/acne inversa: 3\u2011year results of a\u00a0phase 3 open-label extention study. J\u00a0Am Acad Dermatol 80:60\u201369","journal-title":"J Am Acad Dermatol"},{"key":"4848_CR72","doi-asserted-by":"publisher","first-page":"748","DOI":"10.1111\/bjd.19627","volume":"184","author":"CC Zouboulis","year":"2021","unstructured":"Zouboulis\u00a0CC, Readhead\u00a0B, Dudley\u00a0JT (2021) An additional drug repurposing study for hidradenitis suppurativa\/acne inversa. Br J Dermatol 184:748\u2013750","journal-title":"Br J Dermatol"},{"key":"4848_CR73","doi-asserted-by":"publisher","first-page":"1401","DOI":"10.1111\/bjd.15748","volume":"177","author":"CC Zouboulis","year":"2017","unstructured":"Zouboulis\u00a0CC, Tzellos\u00a0T, Kyrgidis\u00a0A et\u00a0al (2017) Development and validation of IHS4, a\u00a0novel dynamic scoring system to assess hidradenitis suppurativa\/acne inversa severity. Br J Dermatol 177:1401\u20131409","journal-title":"Br J Dermatol"}],"updated-by":[{"DOI":"10.1007\/s00105-021-04878-2","type":"erratum","label":"Erratum","source":"publisher","updated":{"date-parts":[[2021,8,23]],"date-time":"2021-08-23T00:00:00Z","timestamp":1629676800000}}],"container-title":["Der Hautarzt"],"original-title":[],"language":"de","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00105-021-04848-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00105-021-04848-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00105-021-04848-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,9,30]],"date-time":"2021-09-30T08:09:06Z","timestamp":1632989346000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00105-021-04848-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,7,2]]},"references-count":73,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2021,8]]}},"alternative-id":["4848"],"URL":"https:\/\/doi.org\/10.1007\/s00105-021-04848-8","relation":{},"ISSN":["0017-8470","1432-1173"],"issn-type":[{"value":"0017-8470","type":"print"},{"value":"1432-1173","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,7,2]]},"assertion":[{"value":"25 May 2021","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 July 2021","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 August 2021","order":3,"name":"change_date","label":"Change Date","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Erratum","order":4,"name":"change_type","label":"Change Type","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Zu diesem Beitrag wurde ein Erratum ver\u00f6ffentlicht:","order":5,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"https:\/\/doi.org\/10.1007\/s00105-021-04878-2","URL":"https:\/\/doi.org\/10.1007\/s00105-021-04878-2","order":6,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Einhaltung ethischer Richtlinien"}},{"value":"M.\u00a0von Laffert und R.E.\u00a0Hunger geben an, dass kein Interessenkonflikt besteht. A.A.\u00a0Navarini erhielt Beratungshonorare f\u00fcr seinen Arbeitgeber und\/oder war Pr\u00fcfarzt und\/oder war medizinischer Autor und\/oder erhielt Grant-Unterst\u00fctzung von AbbVie, Almirall, Amgen, Biomed, BMS, Boehringer Ingelheim, Celgene, Eli Lilly, Galderma, GSK, LEO Pharma, Janssen-Cilag, MSD, Novartis, Pfizer, Pierre Fabre Pharma, Regeneron, Sandoz, Sanofi, UCB Pharma. C.C.\u00a0Zouboulis hat Berater- und Vortragshonorare von Idorsia, Incyte, InflaRx, Janssen, Novartis, Regeneron und UCB erhalten, die nicht mit diesem Manuskript in Verbindung stehen. Seine Abteilung erhielt Honorare von AbbVie, InflaRx, Novartis und UCB f\u00fcr seine Teilnahme an klinischen Studien.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Interessenkonflikt"}},{"value":"F\u00fcr diesen Beitrag wurden von den Autoren keine Studien an Menschen oder Tieren durchgef\u00fchrt. F\u00fcr die aufgef\u00fchrten Studien gelten die jeweils dort angegebenen ethischen Richtlinien.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Interessenkonflikt"}}]}}